Excitingly, the protein levels of GSK3B were significantly downregulated after 24 h of treatment of non-small-cell lung cancer H1299 and A549 with the indicated concentrations of triptonodiol (Fig. 10). The gene discussed is GSK3B; the disease is non-small cell lung carcinoma.